We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+13.45%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$780M
AUM Growth
+$171M
(+28%)
Cap. Flow
+$112M
Cap. Flow
% of AUM
14.34%
Top 10 Holdings %
Top 10 Hldgs %
16.82%
Holding
517
New
169
Increased
169
Reduced
80
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$9.02M |
| 2 |
Broadcom
AVGO
|
+$6.42M |
| 3 |
TSMC
TSM
|
+$6.34M |
| 4 |
MDC
M.D.C. Holdings, Inc.
MDC
|
+$6.09M |
| 5 |
Open Text
OTEX
|
+$5.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fox Class A
FOXA
|
+$9.87M |
| 2 |
Diamondback Energy
FANG
|
+$9.52M |
| 3 |
Home Depot
HD
|
+$7.05M |
| 4 |
MetLife
MET
|
+$6.8M |
| 5 |
Accenture
ACN
|
+$6.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.53% |
| 2 | Consumer Discretionary | 17.87% |
| 3 | Industrials | 15.32% |
| 4 | Healthcare | 12.76% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Xenon Pharmaceuticals
XENE
$6.32B
| $1.71M | 0.22% |
44,422
+17,582
| +66% | +$699K |
|
127
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
| $1.7M | 0.22% |
11,393
+1,275
| +13% | +$184K |
|
128
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.3B
| $1.7M | 0.22% |
33,566
| – | – |
|
129
TJX Companies
TJX
$170B
| $1.7M | 0.22% |
19,994
+2,594
| +15% | +$205K |
|
130
Cannae Holdings
CNNE
$647M
| $1.69M | 0.22% |
83,853
+707
| +0.9% | +$13.6K |
|
131
McDonald's
MCD
$188B
| $1.69M | 0.22% |
5,666
+1,649
| +41% | +$479K |
|
132
Covenant Logistics
CVLG
$1.18B
| $1.67M | 0.21% |
76,410
+44,660
| +141% | +$862K |
|
|
SWAV
133
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.67M | 0.21% |
5,840
-1,765
| -23% | -$490K |
|
134
Coursera
COUR
$1.54B
| $1.67M | 0.21% |
+127,935
| New | +$1.53M |
|
135
Trinity Industries
TRN
$2.97B
| $1.66M | 0.21% |
64,547
+2,915
| +5% | +$66.6K |
|
136
Arcos Dorados Holdings
ARCO
$1.73B
| $1.65M | 0.21% |
160,650
+29,531
| +23% | +$252K |
|
137
Cameco
CCJ
$38.3B
| $1.64M | 0.21% |
52,480
+19,719
| +60% | +$555K |
|
138
AutoZone
AZO
$48.3B
| $1.64M | 0.21% |
659
-31
| -4% | -$79.1K |
|
139
Vertex
VERX
$1.92B
| $1.64M | 0.21% |
84,198
+52,207
| +163% | +$1.1M |
|
140
HealthEquity
HQY
$7.91B
| $1.64M | 0.21% |
25,965
+1,195
| +5% | +$69.3K |
|
141
iShares MBS ETF
MBB
$39B
| $1.63M | 0.21% |
17,518
| – | – |
|
|
AVTA
142
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.62M | 0.21% |
72,586
-116,650
| -62% | -$2.75M |
|
143
Duolingo
DUOL
$5.7B
| $1.62M | 0.21% |
11,316
+3,226
| +40% | +$462K |
|
|
SPR
144
DELISTED
Spirit AeroSystems
SPR
| $1.6M | 0.21% |
54,940
+7,345
| +15% | +$212K |
|
145
American Express
AXP
$223B
| $1.59M | 0.2% |
9,141
+1,079
| +13% | +$174K |
|
|
WIRE
146
DELISTED
Encore Wire Corp
WIRE
| $1.58M | 0.2% |
8,488
+6,175
| +267% | +$1.05M |
|
147
First Merchants
FRME
$2.72B
| $1.58M | 0.2% |
55,835
+2,775
| +5% | +$78.7K |
|
148
Bank of America
BAC
$435B
| $1.57M | 0.2% |
54,678
-5,014
| -8% | -$143K |
|
149
Albany International
AIN
$2.14B
| $1.55M | 0.2% |
16,621
+2,617
| +19% | +$235K |
|
150
Prothena Corp
PRTA
$458M
| $1.5M | 0.19% |
22,039
+14,888
| +208% | +$960K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q2 2023 Portfolio in Review
As of Q2 2023, Advisory Research held 517 positions worth $780M, up 28% from $608M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Advisory Research deployed $112M of net new capital in Q2 2023, opening 169 new positions and adding to 169 existing holdings. Its largest new stake was Merck: 79,479 shares worth $9.17M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Home Depot, an estimated $7.05M trimmed.
- Advisory Research's largest Q2 2023 buy was Merck: 79,479 shares worth $9.17M.
- Advisory Research added most to Broadcom in Q2 2023, an estimated $6.42M increase.
- Advisory Research's biggest Q2 2023 reduction was Home Depot, cutting an estimated $7.05M.
- Advisory Research fully exited Fox Class A in Q2 2023, selling an estimated $9.87M.
- Advisory Research's ten largest holdings make up 17% of its $780M portfolio in Q2 2023.
- Advisory Research opened 169 new positions and closed 81 in Q2 2023.
- Advisory Research's portfolio value rose 28% quarter-over-quarter to $780M.
Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.